Results 211 to 220 of about 541,695 (230)

Decitabine for acute myeloid leukemia

Expert Review of Anticancer Therapy, 2012
Decitabine (Dacogen(®), Eisai Inc., NJ, USA) is a nucleoside analogue DNA methyltransferase inhibitor first synthesized and documented to have antileukemic efficacy over 40 years ago. Over the years, the dosing of decitabine has been refined, such that for acute myeloid leukemia, a 5-day schedule of 20 mg/m(2) is now commonly utilized.
openaire   +3 more sources

Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Leukemia, Myeloid, Acute, Date of authorisation: 24/10/2019, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Acute Myeloid Leukemia

New England Journal of Medicine, 2015
Hartmut, Döhner, Daniel J, Weisdorf, Clara D, Bloomfield   +2 more
openaire   +2 more sources

Venetoclax in acute myeloid leukemia

Expert Opinion on Investigational Drugs, 2023
Bruzzese, Antonella, Martino, Enrica Antonia, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo   +8 more
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Azacitidine Celgene, azacitidine, Myelodysplastic Syndromes,Leukemia, Myelomonocytic, Chronic,Leukemia, Myeloid, Acute, Date of authorisation: 02/08/2019, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Vyxeos, daunorubicin / cytarabine, Leukemia, Myeloid, Acute, Date of authorisation: 23/08/2018, Revision: 1, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Childhood Acute Myeloid Leukemia

Current Treatment Options in Oncology, 2008
Despite the use of intensive chemotherapy and hematopoietic stem cell transplantation, approximately one-third of children with acute myeloid leukemia (AML) still suffer relapse of their disease. It is unlikely that improvements in outcome can be achieved by further intensification of conventional chemotherapy.
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin / cytarabine, Leukemia, Myeloid, Acute, Date of authorisation: 23/08/2018, Revision: 2, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Vyxeos, daunorubicin / cytarabine, Leukemia, Myeloid, Acute, Date of authorisation: 22/08/2018, Status: Authorised

Case Medical Research, 2018

semanticscholar   +1 more source

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Nature Network Boston, 1997
D. Bonnet, J. Dick
semanticscholar   +1 more source